Suchergebnisse - "Pariente, Benjamin"

PubPharm (153)

31

Monitoring of inflammatory bowel disease in 2019 : A French consensus for clinical practice

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2020

von Bonnaud, G. | Bouhnik, Y. | Hagege, H. | +4

CommentIn: Dig Liver Dis. 2020 Jul;52(7):721-722. - PMID 32197889

32

Deep Remission at 1 Year Prevents Progression of Early Crohn's Disease

enthalten in: Gastroenterology | 2020

von Ungaro, R. | Yzet, C. | Bossuyt, P. | +36

33

Editorial : the most commonly used IBD indices still fail to represent real life and subjective patient experience. Author's reply

enthalten in: Alimentary pharmacology & therapeutics | 2020

von Pariente, B.

CommentOn: Aliment Pharmacol Ther. 2020 May;51(9):889-898. - PMID 32221985

34

Oral Curcumin No More Effective Than Placebo in Preventing Recurrence of Crohn's Disease After Surgery in a Randomized Controlled Trial

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2020

von Bommelaer, G. | Laharie, D. | Nancey, S. | +29

35

Effectiveness and safety of ustekinumab induction therapy for 103 patients with ulcerative colitis : a GETAID multicentre real-world cohort study

enthalten in: Alimentary pharmacology & therapeutics | 2020

von Amiot, A. | Filippi, J. | Abitbol, V. | +65

ErratumIn: Aliment Pharmacol Ther. 2020 Nov;52(9):1533. - PMID 33263381

36

Bowel damage and disability in Crohn's disease : a prospective study in a tertiary referral centre of the Lémann Index and Inflammatory Bowel Disease Disability Index

enthalten in: Alimentary pharmacology & therapeutics | 2020

von Lauriot Dit Prevost, C. | Azahaf, M. | Nachury, M. | +7

CommentIn: Aliment Pharmacol Ther. 2020 Jun;51(11):1203-1204. - PMID 32424924

37

Natural History of Perianal Fistulising Lesions in Patients With Elderly-onset Crohn's Disease : A Population-based Study

enthalten in: Journal of Crohn's & colitis | 2020

von Danielou, M. | Sarter, H. | Pariente, B. | +109

38

Ustekinumab Serum Trough Levels May Identify Suboptimal Responders to Ustekinumab in Crohn's Disease

enthalten in: Digestive diseases and sciences | 2020

von Painchart, C. | Brabant, S. | Duveau, N. | +10

39

Vedolizumab for perianal Crohn's disease : a multicentre cohort study in 151 patients

enthalten in: Alimentary pharmacology & therapeutics | 2020

von Chapuis-Biron, C. | Bourrier, A. | Nachury, M. | +26

CommentIn: Aliment Pharmacol Ther. 2020 May;51(9):912-913. - PMID 32285504

40

Real-world evidence of tofacitinib effectiveness and safety in patients with refractory ulcerative colitis

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2020

von Lair-Mehiri, L. | Stefanescu, C. | Vaysse, T. | +15